EU MDR Annex X Type-Examination and Annex XI Product Conformity Verification

1. Key takeaways

Annex X (type-examination) is the route that examines whether one representative sample is conformant, while Annex XI (verification of product conformity) is the route that ensures the batches actually produced remain consistent with the examined type. The two are frequently combined for the higher risk classes, and they can also be used as supplementary modules on top of Annex IX, so the three Annexes do not form a mutually exclusive set of options.

Understanding this modular structure is essential for route planning. A manufacturer choosing the type-examination route is essentially certifying a design: the notified body confirms that the type meets the requirements, and everything that follows depends on production staying within the boundaries of that type. This makes the route attractive for technically mature products with stable designs, and unattractive for products that iterate quickly. The costs that decide between the routes are therefore not only the initial certification costs, but also the recurring costs of every subsequent change, because each change that affects the conformity of the type must go back to the notified body. A route decision made purely on first certification timelines tends to be paid for later during the change management phase.

2. Legal basis

Both entries concern Regulation (EU) 2017/745, adopted on 2017-04-05 and applicable since 2021-05-26. Annex X defines the type-examination procedure in which the notified body assesses the representative sample against the general safety and performance requirements set out in Annex I, and Annex XI defines the two verification sub-routes that keep serial production aligned with the examined type. The technical documentation submitted with the application must follow the structure of Annex II, and the evidence it contains must demonstrate conformity with the Annex I requirements item by item.

3. Expert insights

Insight one: the object of type-examination is the type, not this batch.

Under Annex X, the notified body examines the representative sample submitted by the manufacturer together with its technical documentation, and confirms that the type meets the general safety and performance requirements of Annex I. The certificate covers the type itself; whether every subsequent batch of products remains consistent with that type is controlled by the production quality assurance or product verification elements of Annex XI. Manufacturers sometimes assume that once the type certificate exists, production freedom is unlimited, which is incorrect: the certificate is only valid as long as what is produced corresponds to what was examined. This division of labour between the two Annexes is deliberate, and understanding it prevents both over-confident production changes and unnecessary re-examinations of designs that have not actually shifted.

Insight two: Annex XI is divided into two parts with different functions.

Annex XI provides separately for production quality assurance, which ensures that the manufacturing process continuously produces products conforming to the approved type, and for product verification, which subjects the products themselves to examination and testing. A manufacturer can select between the two sub-routes according to product characteristics and batch size, and can also apply them in addition to the system audit of Annex IX. Choosing the wrong sub-route creates friction: product verification imposes per-batch testing burdens that scale with volume, while production quality assurance requires a mature controlled manufacturing process. The choice should be documented and aligned with the actual production model rather than copied from another project.

Insight three: the type-examination route places higher demands on design freeze.

Once the type is fixed and certified, any design change that affects the conformity of the type must be resubmitted to the notified body. This makes the route suitable for technically mature products with a low change frequency, while for software or electronic products that iterate frequently, the system-based route of Annex IX is usually more flexible. The distinction is not bureaucratic pedantry: every resubmission consumes notified body capacity and calendar time, and a product that changes every quarter can spend more time in re-examination than on the market. Design freeze discipline, including controlled specification extensions and version management, is therefore a prerequisite for choosing this route rather than an afterthought.

Insight four: route selection must consider later change costs, not only first certification costs.

If the selection is made only on the basis of the first certification timeline, the project typically pays a higher price during the post-market change phase. The assessment basis should include the expected change frequency, whether changes require re-examination, the sampling and testing costs of the verification sub-route, and the extensibility of the certificate scope to new models or specifications. Comparing the routes on all four dimensions produces a materially different ranking than comparing them on certification time alone, and the practical estimate of total route cost over the certificate lifetime is the figure that belongs in the decision memo.

4. Practical recommendations

1. Before selecting the route, list the changes expected over the next three years, covering materials, software versions and specification extensions, and use that list to judge which Annex fits the product.
2. When using Annex X, document the rationale for the choice of the representative sample in the application file, explaining the specification range that the sample covers.
3. When using Annex XI, clarify the division of labour between production quality assurance and product verification, and implement that division in the quality management system documentation.
4. Confirm the certificate coverage, including models, specifications and software versions, in the certificate documents, so that later scope extensions do not become disputed interpretations.
5. Write the criteria that trigger re-examination into the design change management procedure, so that engineers can classify changes without case-by-case legal debate.

5. Verification checklist

• □ The available route combinations have been confirmed according to the risk class
• □ The rationale for the choice of the representative sample has been documented
• □ The sub-route of Annex XI (production quality assurance or product verification) has been clarified
• □ The certificate coverage (models, specifications, versions) has been checked
• □ The criteria triggering re-examination for design changes have been written into the procedure
• □ Change costs have been included in the route selection assessment

GRZAN supports manufacturers, authorised representatives and importers across the EU MDR market with CE marking pathway selection and classification strategy, including comparative assessments of Annex X type-examination and Annex XI verification sub-routes against product change profiles. For a practical estimate of certification timelines, sampling scope and documentation effort for your portfolio, contact GRZAN at info@grzanglobal.com.

Regulatory information verified as of 2026-10-29.